$DD

DuPont declares $0.60 dividend (NYSE:DD)

DuPont (DD) declared a $0.60 per share quarterly dividend, maintaining the previous rate. The forward yield is 1.85%. The dividend is payable on December 15 to shareholders of record on November 30, with an ex-dividend date of November 30.

Original reporting
Published Oct 13, 2026, 8:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$DD
Neutral
high confidence
Mentioned
$DD
Relevance
5/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$DDNeutralMed
01

Why it matters

The dividend announcement is a routine corporate action with limited price impact, mainly affecting dividend‑focused investors.

02

Market read

A standard dividend declaration; relevance is primarily for dividend‑capture traders and income‑focused investors.

03

What to watch

Potential tax considerations for dividend‑capture strategies and upcoming earnings guidance.

Relevance 5/10Novelty 6/10Timing: pre‑market today

Background

DuPont (NYSE:DD) regularly announces quarterly dividends; this release confirms the $0.60 per share payout.

Company-level read

Ticker impact

$DDNeutralHigh confidence
Context

DuPont announced a quarterly dividend of $0.60 per share, payable Dec. 15, with ex‑dividend date Nov. 30.

Expected impact

likely modest upside or flat as investors price in the unchanged dividend.

Evidence & confidence

The dividend is in line with prior payouts, so the market impact is limited to short‑term dividend‑capture trades.

Market effects

Provides a modest signal of cash flow stability for the chemicals sector.

Limited to US investors focused on dividend yields.

Low; dividend news is company‑specific.

Counterpoint

Investors may view the unchanged dividend as a lack of growth momentum and could favor higher‑growth peers.

Key entities

  • DuPont de Nemours, Inc.

    Chemical and materials conglomerate issuing the dividend.

Related articles

$DDMed

DD Downgraded by JP Morgan -- Price Target Lowered to $145

JP Morgan downgraded DuPont de Nemours (DD) to Neutral, lowering its price target from $172 to $145. GuruFocus estimates DD is 83.5% overvalued, with a GF Value of $70.97 vs. current price of $130.24. DD's P/E (TTM) is 309.35x, far above its 5-year median of 7.91x. Analysts cite concerns about growth and profitability.

$DDHigh

JPMorgan downgrades DuPont stock rating on recovery outlook

JPMorgan downgraded DuPont (NYSE:DD) to Neutral from Overweight, lowering its price target to $145 from $172. The stock trades at $132.48, considered undervalued. DuPont reported Q2 2026 earnings, beating estimates with $1.88 EPS and $1.82B revenue. BMO Capital reiterated its Outperform rating, maintaining a $186 price target.

$DDMed

Attorney General Todd Rokita leads multistate coalition to stop DuPont shell game, hold companies accountable for PFAS contamination

Attorney General Todd Rokita led a 16-state lawsuit against DuPont (EIDP), Corteva, and Vylor, alleging a transfer of assets to avoid PFAS contamination liabilities. The suit seeks to freeze assets and block dividends or buybacks. Rokita claims the companies moved valuable assets to Vylor, leaving liabilities with DuPont. The hearing is set for October 2, 2026.

$DDLow

Judge says 3M, DuPont, and Honeywell must face Connecticut firefighters' PFAS claims

A U.S. judge ruled that 3M, DuPont, Honeywell, and others must face claims from Connecticut firefighters over PFAS exposure in protective gear. The lawsuit alleges the gear, containing 3M's Scotchlite and DuPont's Kevlar, increased cancer risks. The judge allowed the case to proceed, permitting damages and medical monitoring claims. The companies argue the gear served its protective function. PFAS makers face broader scrutiny, with prior settlements totaling over $11 billion.